Allworth Financial LP Arcellx, Inc. Transaction History
Allworth Financial LP
- $17.4 Billion
- Q1 2025
A detailed history of Allworth Financial LP transactions in Arcellx, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 28 shares of ACLX stock, worth $1,811. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28Holding current value
$1,811% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ACLX
# of Institutions
222Shares Held
44.6MCall Options Held
434KPut Options Held
433K-
Paradigm Biocapital Advisors LP New York, NY4.37MShares$283 Million12.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.99MShares$258 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$242 Million20.37% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$228 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.48MShares$225 Million8.84% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $2.84B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...